合聘教師研究論文(截至20230517)-英文版

1. Ph.D. Program in Drug Discovery and
Development Industry
Journal papers published by our teachers
(date to 20230517)

2. Journal papers published-2023
Data Sources: Research Performance Index System
In Vitro and In Silico Biological Studies of 4-Phenyl-2-quinolone (4-PQ)
Derivatives as Anticancer Agents. Yi-Fong Chen, Bashir Lawal, Li-Jiau Huang,
Sheng-Chu Kuo, Maryam Rachmawati Sumitra, Ntlotlang Mokgautsi, Hung-Yun
Lin, Hsu-Shan Huang#. Molecules. 2023 Jan 5; 28(2): 555.【IF: 4.927 Ranking:
65/179】
Application of Design of Experiments in the Development of Self-
Microemulsifying Drug Delivery Systems. Chien-Ming Hsieh, Ting-Lun Yang,
Athika Darumas Putri, Chin-Tin Chen#. Pharmaceuticals (Basel). 2023 Feb;
16(2): 283.【IF: 5.215 Ranking: 69/279】
Attenuation of hyperglycemia-associated dyslipidemic, oxidative, cognitive, and
inflammatory crises via modulation of neuronal ChEs/NF-kappa B/COX-2/NOx,
and hepatorenal functional deficits by the Tridax procumbens extract. Itam Ako
Hogan, Yu-Cheng Kuo, Asmau N Abubakar, Bashir Lawal, Abdulhakeem R
Agboola, Halimat Yusuf Lukman, Sunday Amos Onikanni, Femi Olawale, Adewale
Oluwaseun Fadaka, Yunusa O Ibrahim, Shukurat B Babalola, Gaber El-Saber
Batiha , Sarah M Albogami, Mohammed Alorabi, Michel De Waard, Hsu-Shan
Huang#. Biomed Pharmacother. 2023 Feb; 158: 114114.【IF: 7.419 Ranking:
26/279】

3. Journal papers published-2023
Data Sources: Research Performance Index System
Development of Furanopyrimidine-Based Orally Active Third-Generation EGFR
Inhibitors for the Treatment of Non-Small Cell Lung Cancer. Mu-Chun Li,
Mohane Selvaraj Coumar, Shu-Yu Lin, Yih-Shyan Lin, Guan-Lin Huang, Chun-
Hwa Chen, Tzu-Wen Lien, Yi-Wen Wu, Yen-Ting Chen, Ching-Ping Chen, Yu-
Chen Huang, Kai-Chia Yeh, Chen-Ming Yang, Bikashita Kalita, Shiow-Lin Pan,
Tsu-An Hsu, Teng-Kuang Yeh, Chiung-Tong Chen, Hsing-Pang Hsieh#. J Med
Chem. 2023 Feb 23; 66(4): 2566-2588.【IF: 8.039 Ranking: 3/63】
Fabrication of Solvent-Free PCL/β-TCP Composite Fiber for 3D Printing:
Physiochemical and Biological Investigation. Sin Ting Ngo, Wei-Fang Lee, Yi-Fan
Wu, Eisner Salamanca, Lwin Moe Aung, Yan-Qiao Chao, Ting-Chia Tsao, Hao-
Wen Hseuh, Yi-Huan Lee, Ching-Chiung Wang#, Wei-Jen Chang#. Polymers
(Basel). 2023 Mar 10; 15(6): 1391.【IF: 4.967 Ranking: 16/90】
Pharmacological and mechanistic study of PS1, a Pdia4 inhibitor, in β-cell
pathogenesis and diabetes in db/db mice. Hui-Ju Tseng#, Wen-Chu Chen #, Tien-
Fen Kuo, Greta Yang, Ching-Shan Feng, Hui-Ming Chen, Tzung-Yan Chen, Tsung-
Han Lee, Wen-Chin Yang#, Keng-Chang Tsai#, Wei-Jan Huang#. Cell Mol Life
Sci. 2023; 80(4): 101. 【IF: 9.234 Ranking: 35/297】

4. Journal papers published-2023
Data Sources: Research Performance Index System
Design, synthesis, and biological evaluation of indolin-2-one derivatives as novel
cyclin-dependent protein kinase 8 (CDK8) inhibitors. Jui-Yi Hsu, Kai-Cheng Hsu,
Ching Sun, Ching-Hsuan Chou, Tony Eight Lin, Tzu-Ying Sung, Hui-Ju Tseng,
Shih-Chung Yen, Chia-Ron Yang#, Wei-Jan Huang#. Biomed Pharmacother. 2023
Mar; 159: 114258 .【IF: 7.419 Ranking: 26/279】
Establishment of extensive artificial intelligence models for kinase inhibitor
prediction: Identification of novel PDGFRB inhibitors. Ssu-Ting Lien, Tony Eight
Lin, Jui-Hua Hsieh, Tzu-Ying Sung, Jun-Hong Chen, Kai-Cheng Hsu#. Comput
Biol Med. 2023 Apr; 156 :106722.【IF: 6.698 Ranking: 13/94】
In silico study of novel niclosamide derivatives, SARS-CoV-2 nonstructural
proteins catalytic residue-targeting small molecules drug candidates. Bashir Lawal,
Sheng-Kuang Tsai, Alexander T H Wu, Hsu-Shan Huang#. Arab J Chem. 2023
May; 16(5) :104654.【IF: 6.212 Ranking: 43/224】

5. Journal papers published-2023
Data Sources: Research Performance Index System
In silico identification and biological evaluation of a selective MAP4K4 inhibitor
against pancreatic cancer. Chao-Di Chang, Min-Wu Chao, Hsueh-Yun Lee, Yi-Ting
Liu, Huang-Ju Tu, Ssu-Ting Lien , Tony Eight Lin, Tzu-Ying Sung, Shih-Chung
Yen, Sing-Han Huang, Kai-Cheng Hsu#, Shiow-Lin Pan#. J Enzyme Inhib Med
Chem. 2023 Dec; 38(1): 2166039.【IF: 5.756 Ranking: 44/322】